4//SEC Filing
Schwabe Stefan K.F. 4
Accession 0001104659-20-024850
CIK 0001356576other
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 5:24 PM ET
Size
6.2 KB
Accession
0001104659-20-024850
Insider Transaction Report
Form 4
Schwabe Stefan K.F.
Executive Vice President R&D
Transactions
- Award
Employee Stock Option (Right to Buy)
2020-02-21+50,000→ 50,000 totalExercise: $23.99Exp: 2030-02-21→ Common Stock (50,000 underlying)
Holdings
- 2,772
Common Stock
Footnotes (2)
- [F1]Includes an aggregate of 458 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan subsequent to the date of the Reporting Person's most recent filing on Form 4.
- [F2]The option vests in four equal annual installments beginning on February 21, 2021.
Documents
Issuer
SUPERNUS PHARMACEUTICALS, INC.
CIK 0001356576
Entity typeother
Related Parties
1- filerCIK 0001557657
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 5:24 PM ET
- Size
- 6.2 KB